Osaic Holdings
ANEB

Osaic Holdings’s Anebulo Pharmaceuticals ANEB Stock Holding History

Osaic Holdings’s Portfolio ANEB Stock Details ANEB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-500
Closed -$3K – 7211
2021
Q4 		$3K Buy
+500
New +$3.32K ﹤0.01% 6844

Other funds holding ANEB

2L
22NW LP Seattle, Washington $146M AUM 29.83% 1-Year Est. Return
MP
Mangrove Partners Greenwich, Connecticut $1.24B AUM 41.74% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Osaic Holdings's ANEB Position: Q1 2022 in Review

Osaic Holdings sold out of Anebulo Pharmaceuticals (ANEB) in Q1 2022, closing a stake of 500 shares — an estimated $3K sold.

Osaic Holdings first reported a position in ANEB in Q4 2021 and held it in 1 quarter. The position peaked at $3K in Q4 2021. 10 funds tracked by Wall St. Rank hold ANEB as of Q1 2022.

  • Osaic Holdings reported no remaining Anebulo Pharmaceuticals position as of Q1 2022 after selling out during the quarter.
  • Osaic Holdings sold 500 Anebulo Pharmaceuticals shares in Q1 2022, an estimated $3K.
  • Osaic Holdings first reported a position in Anebulo Pharmaceuticals in Q4 2021 and held it in 1 quarter.
  • Osaic Holdings's Anebulo Pharmaceuticals position peaked at $3K in Q4 2021.
  • 10 funds tracked by Wall St. Rank held Anebulo Pharmaceuticals as of Q1 2022.

Based on Osaic Holdings's 13F filing for Q1 2022, filed 4 May 2022.